Back
United Therapeutics Stock Predictions
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
50
UTHR
United Therapeutics
Last Price:
364.59
Seasonality Move:
10.82%
7 Day Trial
ALL ACCESS PASS
$
7
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.United Therapeutics Stock Forecast
- Over the next 52 weeks, United Therapeutics has on average historically risen by 23.9% based on the past 25 years of stock performance.
- United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
-
Is United Therapeutics Stock Undervalued?
The current United Therapeutics [UTHR] share price is $364.33. The Score for UTHR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal. - UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, United Therapeutics has on average historically risen by 23.9% based on the past 25 years of stock performance.
United Therapeutics Stock Rating
Sell
50
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics overpriced?
- United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
417.82
52-Week Low:
208.62
Prediction Charts
Market Cap:
16.27B
Price in USD:
364.33
Volume:
192.44K
Beta:
0.53
Technical Analysis
SMA50:
363.31
SMA100:
348.74
SMA200:
300.12
52-Wk Change:
59.1%
Stock Predictions
-
Is United Therapeutics stock public?
Yes, United Therapeutics is a publicly traded company. -
What is the United Therapeutics stock quote today?
The United Therapeutics stock price is 364.33 USD today. -
How to buy United Therapeutics stock online?
You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 375.78 | 374.02 | 377.93 | 370.38 |
| Nov-4 | 373.98 | 376.80 | 379.51 | 371.32 |
| Nov-5 | 373.03 | 382.77 | 382.95 | 373.03 |
| Nov-6 | 392.74 | 397.53 | 399.23 | 389.15 |
| Nov-7 | 397.00 | 402.57 | 405.98 | 394.68 |
| Nov-8 | 403.35 | 410.00 | 417.82 | 403.35 |
| Nov-11 | 412.48 | 400.58 | 412.77 | 399.10 |
| Nov-12 | 401.89 | 400.87 | 406.42 | 396.52 |
| Nov-13 | 400.02 | 400.60 | 405.53 | 398.97 |
| Nov-14 | 400.45 | 386.27 | 401.53 | 385.47 |
| Nov-15 | 385.19 | 363.25 | 385.19 | 359.11 |
| Nov-18 | 363.00 | 359.21 | 363.00 | 355.79 |
| Nov-19 | 355.71 | 360.71 | 363.36 | 353.65 |
| Nov-20 | 362.17 | 364.33 | 365.67 | 359.40 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.